Sort
39,280 grants matching “leukemia”
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
$352,275Michael A Caligiuri · Ohio State University · R01 · FY2016 · CA
Targeting PTPN11 dependent Hematologic Malignancies
$352,275Bill H Chang · Oregon Health & Science University · R01 · FY2020 · CA
Improving BTK Directed Therapy for CLL
$352,275Jennifer A. Woyach · Ohio State University · R01 · FY2015 · CA
Improving BTK Directed Therapy for CLL
$352,275Jennifer A. Woyach · Ohio State University · R01 · FY2018 · CA
Overcoming Leukemia Chemoresistance in the Central Nervous System
$352,275Peter M Gordon · University Of Minnesota · R37 · FY2020 · CA
Improving BTK Directed Therapy for CLL
$352,275Jennifer A. Woyach · Ohio State University · R01 · FY2017 · CA
Biology and Targeting of noncoding RNAs in AML
$352,275Ramiro Garzon · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia
$352,275Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2021 · CA
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$352,270Birgit Knoechel · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
IN UTERO TRANSFER OF HEMATOPOIETIC CELLS
$352,261University Of Minnesota Twin Cities · R01 · FY2003 · HL
The role of PTEN phosphorylation remodeling in hematopoietic stem cell regulation
$352,252Jiwang Zhang · Loyola University Chicago · R01 · FY2013 · HL
Targeting CCR7 for the Prevention/Treatment of GvHD
$352,240Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2013 · HL
Functional analysis of leukemic CREBBP mutations
$352,231Charles G. Mullighan · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$352,231Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Validating Syk as a Target for AML Therapy
$352,231Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
$352,231Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Validating Syk as a Target for AML Therapy
$352,231Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
$352,231Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Molecular Targeted Therapy for Retinoblastoma
$352,231Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Optimizing treatment decision by accounting for longitudinal biomarker trajectories and competing risks of each individual
$352,166Xuelin Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
CHILDRENS CANCER GROUP
$352,161Children'S Research Institute · U10 · FY2001 · CA
Painted erythrocyte carriers for therapy of acute myeloid leukemia
$352,151Dmitri Simberg · University Of Colorado Denver · R01 · FY2020 · CA
Painted erythrocyte carriers for therapy of acute myeloid leukemia
$352,151Dmitri Simberg · University Of Colorado Denver · R01 · FY2017 · CA
Painted erythrocyte carriers for therapy of acute myeloid leukemia
$352,151Dmitri Simberg · University Of Colorado Denver · R01 · FY2018 · CA
Painted erythrocyte carriers for therapy of acute myeloid leukemia
$352,151Dmitri Simberg · University Of Colorado Denver · R01 · FY2016 · CA